The top 100 stock
market authors
selected for publication
market authors
selected for publication
Glaxosmithkline plc (GSK) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Glaxosmithkline plc (GSK) by latest | most commented
- FDA Calendar Updates: Rigel Pharma, GlaxoSmithKline, Eisai, SuperGen
- Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
- Generic Players Continue to Impress in H1
- FDA Helps Investors Look Past Box Warnings
- European Dividend Trends
- Opportunities in Options Markets, Summer 2009
- Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
- Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines
- FDA Extreme Trades: 16 Stocks Under 5 Bucks
- Pharma M&A: Big Bonds and Small Deals
- Revisiting an Options Strategy from 2008
- GlaxoSmithKline Thinks It's Turning Things Around
- Pharma Announces $80B Reduction: Who Wins?
- Glaxo: Despite Sales and Generics Problems, Fundamentals Are Sound
- A Healthy Dose of Funding for Pharma, Biotech
- Fast Money Recap: Mister Softee No More? (6/16/09)
- Companies Involved in the Treatment of Swine Flu
- FDA Calendar Updates: BioDelivery Sciences Worth the Wait
- Obama's Healthcare Reform: 2 Winners, 2 Losers
- Wall Street Breakfast: Must-Know News
- FDA Calendar: 18 Hot Summer Trades
- Dollar Rallies on Lower than Expected European Industrial Production
- China Biotech in Review: Moving Forward
- Bank of America Day in the Markets
- FDA Calendar Updates: BDSI, SVNT Deadlines Approach
- Preview from Europe: Stocks Find Solace in the Beige Book
- Antigenics: Long Play with a Shot of Potential
- New Drug Approvals on Pace to Exceed 2008 Total
- Astra Zeneca Short Base Still High, But Declining
- GSK Seeks to Increase Emerging Markets Presence with New Vaccine JV
- Human Genome Sciences, GlaxoSmithKline: Diabetes Data Looks Good
- FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
- Life Science Companies Get Boost from Capital Markets
- Biovail: Dividend Cut, Recent Acquisition Positive for Shareholders
- Glaxo Does a Deuterium Deal
- Berkshire Hathaway Stock Holdings and Investment Ideas
- Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth?
- Vanda Pharmaceuticals: Tomorrow's Headline Stock
- FDA Calendar Updates: AstraZeneca, GlaxoSmithKline, Sanofi-Aventis
- Swine Flu: A Follow-Up on 'Trading the Hype'
- Swine Flu: Trade Smartly, Beware the Hype
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Bill Gross
-
3
Tyler Durden
-
4
Philip Davis
-
5
TraderMark
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
